Paper42428883
Design and Synthesis of Novel Chalcogen-1,2,4-triazoles as Lead-like Glutathione Peroxidase-Mimetic Antioxidants.
Santos NLB and 5 others. ACS Omega, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Design and Synthesis of Novel Chalcogen-1,2,4-triazoles as Lead-like Glutathione Peroxidase-Mimetic Antioxidants. Papers, record 42428883. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42428883
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Design and Synthesis of Novel Chalcogen-1,2,4-triazoles as Lead-like Glutathione Peroxidase-Mimetic Antioxidants.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34846405 | Glutathione peroxidase mimics based on conformationally-restricted, peri-like, 4,5-disubstituted fluorene dichalcogenides. | Org Biomol Chem | 2021 | https://conductscience.org/library/papers/34846405 | PubMed |
| 2 | 39880296 | Chalcogen dihydrobenzofuran compounds as potential neuroprotective agents: An in vitro and in silico biological investigation. | Biochimie | 2025 | https://conductscience.org/library/papers/39880296 | PubMed |
| 3 | 38293899 | Aminic Organoselenium Compounds as Glutathione Peroxidase Mimics and Inhibitors of Ferroptosis. | Chembiochem | 2024 | https://conductscience.org/library/papers/38293899 | PubMed |
| 4 | 36226121 | Synthesis methods of 1,2,3-/1,2,4-triazoles: A review. | Front Chem | 2022 | https://conductscience.org/library/papers/36226121 | PubMed |
| 5 | 33655868 | Diselenides and Selenocyanates as Versatile Precursors for the Synthesis of Pharmaceutically Relevant Compounds. | Curr Org Synth | 2022 | https://conductscience.org/library/papers/33655868 | PubMed |
| 6 | 39711134 | Organoselenium compounds beyond antioxidants. | Future Med Chem | 2024 | https://conductscience.org/library/papers/39711134 | PubMed |
| 7 | 29168872 | Organoselenium compounds as mimics of selenoproteins and thiol modifier agents. | Metallomics | 2017 | https://conductscience.org/library/papers/29168872 | PubMed |
| 8 | 28489107 | A novel metal-free method for the selenocyanation of aromatic ketones to afford α-carbonyl selenocyanates. | Org Biomol Chem | 2017 | https://conductscience.org/library/papers/28489107 | PubMed |
| 9 | 15231062 | In vitro evaluation of glutathione peroxidase (GPx)-like activity and antioxidant properties of some Ebselen analogues. | Redox Rep | 2004 | https://conductscience.org/library/papers/15231062 | PubMed |
| 10 | 34932346 | How Solvation Influences the SN2 versus E2 Competition. | J Org Chem | 2022 | https://conductscience.org/library/papers/34932346 | PubMed |
| 11 | 25244678 | Synthesis and biological evaluation of new nitrogen-containing diselenides. | Eur J Med Chem | 2014 | https://conductscience.org/library/papers/25244678 | PubMed |
| 12 | 28471109 | Ethaselen: a novel organoselenium anticancer agent targeting thioredoxin reductase 1 reverses cisplatin resistance in drug-resistant K562 cells by inducing apoptosis. | J Zhejiang Univ Sci B | 2017 | https://conductscience.org/library/papers/28471109 | PubMed |
| 13 | 30043018 | Ion-pairing catalysis in the enantioselective addition of hydrazones to N-acyldihydropyrrole derivatives. | Chem Commun (Camb) | 2018 | https://conductscience.org/library/papers/30043018 | PubMed |
| 14 | 21247117 | Open vessel and cooling while heating microwave-assisted synthesis of pyridinyl N-aryl hydrazones. | ACS Comb Sci | 2011 | https://conductscience.org/library/papers/21247117 | PubMed |
| 15 | 37478558 | Recent advances in 1,2,3- and 1,2,4-triazole hybrids as antimicrobials and their SAR: A critical review. | Eur J Med Chem | 2023 | https://conductscience.org/library/papers/37478558 | PubMed |
| 16 | 39026642 | Design, synthesis, and structure-activity relationship studies of 6,7-dihydro-5H-pyrrolo[1,2-b][1,2,4]triazole derivatives as necroptosis inhibitors. | RSC Med Chem | 2024 | https://conductscience.org/library/papers/39026642 | PubMed |
| 17 | 38871111 | Selenium-containing compounds: a new hope for innovative treatments in Alzheimer's disease and Parkinson's disease. | Drug Discov Today | 2024 | https://conductscience.org/library/papers/38871111 | PubMed |
| 18 | 40766767 | Synthetic and semi-synthetic antioxidants in medicine and food industry: a review. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40766767 | PubMed |
| 19 | 34044345 | Bifunctional chiral selenium-containing 1,4-diarylazetidin-2-ones with potent antitumor activities by disrupting tubulin polymerization and inducing reactive oxygen species production. | Eur J Med Chem | 2021 | https://conductscience.org/library/papers/34044345 | PubMed |
| 20 | 24752799 | Design, synthesis and evaluation of seleno-dihydropyrimidinones as potential multi-targeted therapeutics for Alzheimer's disease. | Org Biomol Chem | 2014 | https://conductscience.org/library/papers/24752799 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42428883
GET https://conductscience.org/api/papers/v1/42428883/references?page=2